nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Diclofenamide—glaucoma	0.293	0.354	CbGbCtD
Ximelagatran—CYP2C9—Dorzolamide—glaucoma	0.283	0.342	CbGbCtD
Ximelagatran—CYP2C9—Methazolamide—glaucoma	0.252	0.305	CbGbCtD
Ximelagatran—F2—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—DHPS—glaucoma	0.0215	0.124	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—C1QB—glaucoma	0.00551	0.0318	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00487	0.0282	CbGpPWpGaD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—MMP1—glaucoma	0.00471	0.0272	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00443	0.0256	CbGpPWpGaD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—MMP2—glaucoma	0.00364	0.0211	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TXN—glaucoma	0.00356	0.0206	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—DHPS—glaucoma	0.00351	0.0203	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ABCA1—glaucoma	0.00341	0.0197	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—OPN4—glaucoma	0.00326	0.0188	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—FN1—glaucoma	0.00307	0.0177	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD1—glaucoma	0.00304	0.0176	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PTGFR—glaucoma	0.00293	0.017	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00291	0.0168	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MYLK—glaucoma	0.0029	0.0168	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.00284	0.0164	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ABCA1—glaucoma	0.00277	0.016	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.00273	0.0158	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00262	0.0152	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD1—glaucoma	0.00247	0.0143	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—MMP9—glaucoma	0.00246	0.0142	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MTHFR—glaucoma	0.00241	0.0139	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.00225	0.013	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—APOE—glaucoma	0.00224	0.013	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ABCA1—glaucoma	0.0022	0.0127	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—CTSA—glaucoma	0.00219	0.0127	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00216	0.0125	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.00215	0.0124	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—C3—glaucoma	0.00214	0.0124	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD1—glaucoma	0.00196	0.0113	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MTHFR—glaucoma	0.00196	0.0113	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—MMP9—glaucoma	0.00196	0.0113	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00194	0.0112	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—NOS3—glaucoma	0.00192	0.0111	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.00182	0.0105	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.00171	0.00986	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—DHPS—glaucoma	0.00167	0.00964	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—OPN4—glaucoma	0.00164	0.00949	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MTHFR—glaucoma	0.00156	0.009	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00153	0.00885	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTGFR—glaucoma	0.00148	0.00855	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—MMP1—glaucoma	0.00136	0.00788	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—CAV1—glaucoma	0.00131	0.00755	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—FN1—glaucoma	0.00124	0.00719	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.00124	0.00717	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00112	0.0065	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.00105	0.00609	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTSA—glaucoma	0.00104	0.00601	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—glaucoma	0.00104	0.00599	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—glaucoma	0.000992	0.00574	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—EDN1—glaucoma	0.000974	0.00564	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000972	0.00562	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—EDN1—glaucoma	0.000962	0.00556	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000959	0.00554	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE2—glaucoma	0.000957	0.00553	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.00094	0.00543	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—OPN4—glaucoma	0.000928	0.00537	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—FN1—glaucoma	0.000896	0.00518	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000872	0.00504	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—glaucoma	0.000843	0.00488	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OPN4—glaucoma	0.000843	0.00487	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—C3—glaucoma	0.000841	0.00486	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTGFR—glaucoma	0.000835	0.00483	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000788	0.00455	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTGFR—glaucoma	0.000759	0.00439	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SMO—glaucoma	0.000745	0.00431	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—glaucoma	0.000744	0.0043	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LRP12—glaucoma	0.000718	0.00415	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—glaucoma	0.00067	0.00387	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000654	0.00378	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000645	0.00373	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB2—glaucoma	0.000639	0.0037	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000564	0.00326	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000525	0.00304	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PAX6—glaucoma	0.00051	0.00295	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000507	0.00293	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OPN4—glaucoma	0.000498	0.00288	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—EDN1—glaucoma	0.000491	0.00284	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SOD1—glaucoma	0.000484	0.0028	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HEYL—glaucoma	0.000463	0.00268	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTGFR—glaucoma	0.000448	0.00259	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—C3—glaucoma	0.000429	0.00248	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000418	0.00242	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000413	0.00239	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000391	0.00226	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SMO—glaucoma	0.000383	0.00221	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000374	0.00216	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MMP1—glaucoma	0.000369	0.00214	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA5A—glaucoma	0.000368	0.00213	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NARFL—glaucoma	0.000368	0.00213	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CAV1—glaucoma	0.000354	0.00205	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RPTOR—glaucoma	0.000351	0.00203	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCK2—glaucoma	0.00034	0.00196	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—FN1—glaucoma	0.000337	0.00195	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000334	0.00193	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.00033	0.00191	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP1—glaucoma	0.000291	0.00168	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HDAC9—glaucoma	0.000289	0.00167	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—EDN1—glaucoma	0.000278	0.00161	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—glaucoma	0.000268	0.00155	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDN1—glaucoma	0.000252	0.00146	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—C3—glaucoma	0.000243	0.0014	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SMO—glaucoma	0.000226	0.00131	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—glaucoma	0.000225	0.0013	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—C3—glaucoma	0.00022	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK2—glaucoma	0.000207	0.0012	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—glaucoma	0.000193	0.00112	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA1—glaucoma	0.00018	0.00104	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGFR—glaucoma	0.000177	0.00103	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CTSA—glaucoma	0.000174	0.00101	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK1—glaucoma	0.000168	0.000974	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA2—glaucoma	0.000164	0.000951	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000161	0.000929	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000161	0.000929	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN2B—glaucoma	0.000155	0.000898	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDN1—glaucoma	0.000149	0.000862	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—glaucoma	0.000146	0.000843	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGF—glaucoma	0.000137	0.000792	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—C3—glaucoma	0.00013	0.000753	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—glaucoma	0.000121	0.000701	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—glaucoma	0.00012	0.000694	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TXN—glaucoma	0.000116	0.00067	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FN1—glaucoma	0.000114	0.000661	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BAD—glaucoma	0.000113	0.000653	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000106	0.000611	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000105	0.000605	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—glaucoma	9.08e-05	0.000525	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—glaucoma	8.98e-05	0.000519	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1B—glaucoma	7.86e-05	0.000455	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—glaucoma	7.28e-05	0.000421	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.24e-05	0.000419	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCA1—glaucoma	7.16e-05	0.000414	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1B1—glaucoma	7.16e-05	0.000414	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—glaucoma	6.54e-05	0.000378	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—glaucoma	5.72e-05	0.000331	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—glaucoma	5.06e-05	0.000292	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—glaucoma	4.94e-05	0.000286	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—glaucoma	4.71e-05	0.000272	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—glaucoma	4.66e-05	0.00027	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—glaucoma	3.53e-05	0.000204	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—glaucoma	3.22e-05	0.000186	CbGpPWpGaD
